Tag: access to treatment

"Siempre tenemos la esperanza de que las cosas mejoren en el futuro y de que, algún día, consigamos encontrar una cura definitiva para la esclerosis múltiple. Hasta entonces, tenemos que seguir las investigaciones más recientes".

A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS

Advocating for the addition of MS treatments to the WHO Essential Medicines List

New publication highlights regional disparities in the management of MS

MS organisations across MENA use their collective voice to advocate for safe and effective MS treatment in a new regional charter

New research explores challenges around MS management in the region.

Access to treatment is a high priority for most people with MS. Convince decision-makers that MS treatments should be available in all health systems.

Addressing barriers to accessing MS healthcare at a global, regional and national level.

'To even get my diagnosis I had to borrow money from others.'

'I keep worrying: What if I was unable to get my treatment for a month or so? What will be the consequences?'

'I felt down, empty and lonely when I couldn’t go to the school.'

‘I don't count how many times I fall. I count how many times I stand up.’

‘She went to sleep and didn’t wake up for two months’

‘They said ‘if a car is broken, it is useless to repair a tyre when the major problem is the engine’

‘I actually want to be in a more corporate kind of role in which you would be married to your job a bit more. That excites me.’

Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time

MSIF and neurological organisations' statement during the Essential Medicines List Committee open session

Advocacy examples from the global MS movement to inspire you today.

'I was left in a situation of being newly diagnosed, scared and with the prospect that I didn't have health coverage.'

Advocating for the addition of MS treatments to the WHO Essential Medicines List

MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders, including MS